PPRI Report - Comparative analysis of pharmaceutical pricing and reimbursement policies in 47 countries

This PPRI Report 2018 provides an overview of pharmaceutical pricing and reimbursement policies in the 47 PPRI member countries.

To facilitate affordable and equitable access to essential and cost-effective medicines for patients, governments can use a mix of policy measures. For the implementation and optimisation of such policies, policy-makers benefit from information and evidence of appropriate measures in other countries and their impacts. 

Link to the report

About PPRI
 
_{Last update: 28 November 2019}